Arizona Tribune - Boulevard

NYSE - LSE

CMSD	0.18%	22.63	$
BCC	-0.51%	80.17	$
RBGPF	-19.57%	69	$
RIO	1.15%	98.26	$
JRI	0.31%	13.02	$
NGG	-0.03%	90.29	$
BCE	-2.31%	23.35	$
CMSC	0.18%	22.43	$
AZN	-0.47%	204.03	$
BTI	-0.07%	58.81	$
GSK	-0.26%	58.21	$
RELX	-0.12%	33.3	$
VOD	-1.02%	15.69	$
RYCEF	-1.59%	16.96	$
BP	1.16%	46.44	$

Featured

Benin leans into painful past to attract tourists

Tourists crowded beneath the Door of No Return, an arch built by the beach at Ouidah in southern Benin in memory of those crammed onto slave ships bound for the New World.

Panic buttons, undercover cops: How Peru bus drivers try to stay safe

From undercover police to panic buttons, bus drivers in Peru's capital Lima are pulling out all the stops to protect themselves from attack by extortion gangs, a key theme in Sunday's presidential election.

Last news

Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing

Tivic Reports Third Quarter 2025 Financial Results

Continues Execution of Strategic Transformation and Advancement of Biologics Pipeline

ADM Tronics Reports Second Quarter of Fiscal Year 2026 Results

NORTHVALE, NJ / ACCESS Newswire / November 14, 2025 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its second fiscal quarter ended September 30, 2025 of Fiscal Year 2026.

Ensysce Biosciences Reports Third Quarter 2025 Financial Results

~ Third Quarter Highlighted by Initiation of Phase 3 Study of PF614, Underscoring Progress Toward Market Readiness and Commitment to Novel Opioid Solutions ~~ Further Program Advancement Supported by Preferred Stock Financing ~

CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results

SOUTH SAN FRANCISCO, CA / ACCESS Newswire / November 14, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on the development of CID-103, a potential best-in-class, anti-CD38 monoclonal antibody for patients with organ transplant rejection and autoimmune diseases, today reported business and financial results for the quarter ended September 30, 2025 (the "third quarter").

Noble Roman's Announces Significant Third Quarter Earnings Growth and Other Company Highlights

INDIANAPOLIS, IN / ACCESS Newswire / November 14, 2025 / Noble Roman's, Inc. (OTCQB:NROM), the Indianapolis based franchisor of Noble Roman's Pizza and Noble Roman's Craft Pizza & Pub, today announced third quarter 2025 financial data, other recent company highlights, and details for a conference call to be held on Monday, November 17th at 4 PM ET.

Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

- Dermata announced a strategic pivot to develop and commercialize over-the-counter (OTC) skin care treatments -- Dermata plans to launch its first OTC product, a once weekly acne kit with its Spongilla technology, in the middle of 2026 -

Relief Therapeutics Shareholders Approve Business Combination with NeuroX

Shareholders approve all EGM proposals related to the combination with NeuroXBusiness combination expected to close in December 2025Relief to be renamed MindMaze Therapeutics Holding SA upon closingNew board and executive committee members announcedCompanies to host joint press conference on November 25, 2025

Luvu Brands Announces First Quarter Fiscal 2026 Results and Operational Highlights

ATLANTA, GA / ACCESS Newswire / November 14, 2025 / Luvu Brands, Inc. (OTCQB:LUVU), a vertically integrated designer, manufacturer, and marketer of consumer lifestyle brands, today reported financial and operational results for the first quarter of fiscal 2026, ended September 30, 2025.

Tom Brady 1/1 NFL Shield Autograph Card Hits Fanatics Collect Premier Auction Through Medical Care Technologies Inc. (OTC PINK:MDCE) Subsidiary Infinite Auctions

With 6-figure expectations this one of one 2009 Topps Unique Tom Brady card featuring a game-worn NFL Equipment patch and autograph is now live at Fanatics Collect's Premier Auction that ends Thursday, November 20, 2025 at 9:30 PM Eastern Time (EST).

Pet-Food Revolution: Two New Global Surveys Reveal Growing Guardian Openness to Sustainable Diets for Dogs and Cats

LONDON, UK / ACCESS Newswire / November 14, 2025 / Two pioneering studies published in the journal Animals have explored in depth how dog and cat guardians perceive more sustainable pet food options. Led by Jenny L. Mace, Alexander Bauer, Andrew Knight and Billy Nicholles, the research sheds new light on the potential for alternative proteins and plant-based diets in the companion animal sector.

Wellgistics Health to Distribute Tollo Health GLP-1 Companion Muscle Loss Medical Food to Pharmacies & Physicians

Company to offer the first clinically validated dietary management of sarcopenia, now available for GLP-1 muscle loss, positioning Wellgistics to help 6,500+ independent pharmacy network (‘Pharmacy Network') and telehealth partners mitigate patient muscle loss in the GLP-1 drug market, estimated to grow to $150 billion by 2030Company to offer first SARS-CoV-2 related natural antiviral combo for Long COVID with addition of 3CL protease inhibitor supplement Tollovid® to Galectovid 1 & 3 inhibitor Medical Food Galectovid® distribution agreement to Pharmacy Network & physicians

Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance

-Targets $3 Billion "Almost-Pumper" Market with First Simplified and Removable/Replaceable Insulin Patch Pump- Aims to Improve Patient and Clinician Experience for the Care of Diabetes

Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates

Click here to registerCompany plans to file its Earnings Report on November 14, 2025 on Form 10-Q for the quarter ended September 30, 2025

NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th - NV-387 is Effective Against H3N2

SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting today, Friday, November 14th, at 11:25am ET at the Pharma Partnering Summit 2025 held at the Hilton Boston Logan Airport in Boston, MA.

Tenon Medical Announces Closing of $2.85 Million At-The-Market PIPE Financing

LOS GATOS, CA / ACCESS Newswire / November 14, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced the successful closing of its previously announced at-the-market private investment in public equity (the "PIPE") financing.

TRNR Reports Record Third Quarter 2025 Results with 139% YoY Growth; Reiterates 2025 Pro Forma Revenue Guidance of $80M+ To Be Driven by Completion of Sportstech Acquisition

Quarterly Results Reflect First Full Quarter Including Wattbike (Acquisition Closed July 1)Company Reports Record Quarterly Revenue of $4.8 Million; Net Loss and Loss per Diluted Share of $5.2 Million and $3.11; Quarterly Adjusted EBITDA Loss of $2.9 million, Due to Low Inventory AvailabilitySportstech Acquisition Expected to Close in 2025 Based on Key Closing Milestone AchievementsReiterates 2025 Pro Forma Revenue Guidance of more than $80 million and Fourth Quarter Profitability Guidance

Forecasted Heavy Rain Prompts Postponement of Compassion Center Coalition for Patient Rights Inaugural Hoedown to Dec. 13

Outdoor toy-drive event rescheduled to prioritize safety as Las Vegas faces 70-90% chance of rain on Saturday

Encision Reports Second Quarter Fiscal Year 2026 Results

BOULDER, CO / ACCESS Newswire / November 14, 2025 / Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2026 second quarter that ended September 30, 2025.

Europe court orders Poland pay damages to woman who aborted abroad

Europe's top rights court Thursday ruled that Poland had interfered with the private life of a woman who had an abortion abroad because she was unsure it was legal at home.

EU lawmakers back proxy voting for pregnant women, new mothers

Pregnant lawmakers and new mothers will get the right to vote by proxy in the European Parliament under a rule change backed Thursday by the assembly, and now headed to member states for approval.

Pakistan grants lifetime immunity to president, current army chief

Pakistan's parliament approved a sweeping constitutional amendment on Thursday granting lifetime immunity to the president as well as the current army chief, a move critics warned would erode democratic checks and judicial independence.

Electronic Caregiver Announces Breakthrough Results from National Medicare Test of Addison Care(R), Demonstrating Unprecedented Patient Engagement, High Reliability, and Scalability for Nationwide Rollout

LAS CRUCES, NEW MEXICO / ACCESS Newswire / November 13, 2025 / Electronic Caregiver, Inc. today announced outstanding clinical performance from a multi-state Medicare service test of Addison Care®, the industry's first 3D Virtual Caregiver designed to support chronically ill older adults at home with 24/7 intelligent care, guidance, and daily engagement.

Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025

WINNIPEG, MB / ACCESS Newswire / November 13, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present Financial Results for the quarter ended September 30, 2025 via conference call on November 20, 2025 at 8:30 am Eastern Time. The Financials for the quarter ended September 30, 2025 will be filed after market close on November 19, 2025.

Mosaic Completes Offering of an Aggregate $900 Million of 3-Year and 5-Year Senior Notes

TAMPA, FL / ACCESS Newswire / November 13, 2025 / The Mosaic Company (NYSE:MOS) today announced that it has completed an underwritten public offering (the "Offering") of $500 million aggregate principal amount of 4.350 percent senior notes due January 2029 and $400 million aggregate principal amount of 4.600 percent senior notes due November 2030 (collectively, the "Notes").

Tenon(R) Medical Reports Third Quarter 2025 Financial Results

~ Record revenue of $1.2 million, a 32% year-over-year increase, reflecting record volume in Catamaran® SI Joint Fusion System procedures and the addition of SImmetry® SI Joint Fusion Product Sales ~~ SImmetry®+ alpha launch in Q4 2025 advances strategic portfolio ~~ Foundation set for sustained growth through portfolio diversification, commercial expansion and operational alignment ~~ Subsequent to quarter end the Company announced the pricing of a PIPE financing with an industry supportive investor cohort raising total gross proceeds of $2.85 million ~

CV Sciences, Inc. Reports Third Quarter 2025 Financial Results

SAN DIEGO, CA / ACCESS Newswire / November 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended September 30, 2025.

Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results

Total net revenue of $13.9 millionNet income of $2.0 million, or $0.21 net income per share basicAdjusted EBITDA1 of $(0.6) million, which includes EXXUA launch investments$32.6 million cash balance at September 30, 2025Company remains on track to launch EXXUA™ (gepirone) extended-release tablets ("EXXUA") in the fourth calendar quarter of 2025 as a centerpiece of its commercial efforts as it enters the over $22 billion United States prescription major depressive disorder ("MDD") marketCompany to host conference call and webcast today, November 13, 2025, at 4:30 p.m. Eastern time

Newsmax Announces Third Quarter 2025 Financial Results

Company Reports Revenues of $45.3 million, a 4.0% Year-Over-Year Increase, Outpacing Election-Year ComparisonBroadcast Revenues Increase to $36.6 Million, a 10.1% Increase Year-Over-YearNewsmax Remains the Fourth Highest-Rated Cable News Channel With Over 28 Million Quarterly Viewers

Trifecta Partners with Prado to Make Healthy Meal Delivery Eligible for HSA/FSA Use

Making Medically Approved Meals More Accessible Nationwide for People Managing Chronic Conditions

Premiere Columbus 2025 Delivers Education, Inspiration, and New Experiences for Midwest Beauty Pros

COLUMBUS, OH / ACCESS Newswire / November 13, 2025 / Premiere Show Group, the nation's leading network of beauty industry events and professional education, successfully concluded Premiere Columbus 2025, energizing the Midwest beauty community with two days of world-class education, high-energy competition, and innovative attendee experiences. Held September 14-15 at the Greater Columbus Convention Center, the show brought together 10,000 visits of licensed professionals and students alongside 129 exhibiting brands for a weekend of skill-building, discovery, and networking.

Cosmoprof North America Miami Returns for Its Third Edition, January 27-29, 2026: Staying Ahead in Beauty, Innovation, and Industry Insights

More than 800 brands and suppliers unite in Miami to showcase the future of beauty across skin care, makeup, fragrance, hair, nails, and the entire supply chain.

Arizona Tribune - Boulevard (English)